Stanley-Laman Group, Ltd. - Q3 2019 holdings

$405 Million is the total value of Stanley-Laman Group, Ltd.'s 265 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 100.0% .

 Value Shares↓ Weighting
IDEX ExitIDEANOMICS INC$0-10,000
-100.0%
-0.01%
SXT ExitSENSIENT TECHNOLOGIE$0-2,667
-100.0%
-0.05%
ALNY ExitALNYLAM PHARMACEUTL$0-3,023
-100.0%
-0.05%
MKSI ExitMKS INSTRUMENTS INC$0-2,862
-100.0%
-0.05%
INGR ExitINGREDION INC$0-2,754
-100.0%
-0.05%
ROK ExitROCKWELL AUTOMATION$0-1,428
-100.0%
-0.06%
REGN ExitREGENERON PHARMS INC$0-757
-100.0%
-0.06%
VWO ExitVANGUARD FTSE EMERGING MARKETS ETFftse emr mkt etf$0-5,557
-100.0%
-0.06%
BLUE ExitBLUEBIRD BIO INC$0-1,912
-100.0%
-0.06%
LSXMA ExitLIBERTY MEDIA CORP SERIES A LIBERTY SIRIUS XM$0-6,547
-100.0%
-0.06%
NATI ExitNTNL INSTRUMENTS$0-5,998
-100.0%
-0.06%
ORTX ExitORCHARD THERAPEUTICS L F UNSPONSORED ADR 1 ADR REPS ORD SHSads$0-18,278
-100.0%
-0.06%
VKTX ExitVIKING THERAPEUTICS$0-30,815
-100.0%
-0.06%
ESTC ExitELASTIC N V F$0-3,487
-100.0%
-0.06%
RARE ExitULTRAGENYX PHARMA$0-4,080
-100.0%
-0.06%
MYOK ExitMYOKARDIA INC 00500$0-5,266
-100.0%
-0.06%
FOLD ExitAMICUS THERAPEUTICS$0-21,082
-100.0%
-0.06%
MORN ExitMORNINGSTAR INC$0-1,872
-100.0%
-0.06%
BL ExitBLACKLINE INC$0-5,186
-100.0%
-0.07%
SGMO ExitSANGAMO THERAPEUTICS$0-27,059
-100.0%
-0.07%
GRTS ExitGRITSTONE ONCOLOGY INC$0-28,125
-100.0%
-0.08%
SQ ExitSQUARE INC CLASS Acl a$0-4,489
-100.0%
-0.08%
DXCM ExitDEXCOM INC$0-2,173
-100.0%
-0.08%
SRPT ExitSAREPTA THERAPEUTICS$0-2,168
-100.0%
-0.08%
ExitSINAR MAS MULTIARTHA TBK IDR 5000.0$0-886,900
-100.0%
-0.14%
ExitSEMIRARA MINING AND POWER CORPORATI$0-1,607,090
-100.0%
-0.17%
ExitCHROMA ATE INC TWD 10.0$0-205,660
-100.0%
-0.22%
ExitAIRPORTS OF THAILAND PCL THB 1.0$0-406,794
-100.0%
-0.23%
LLL ExitL3 TECHNOLOGIES INC MANDATORY MERGER EFF: 07/01/19$0-5,602
-100.0%
-0.33%
HRS ExitHARRIS CORP NAME CHANGE EFF: 07/01/19$0-31,424
-100.0%
-1.43%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-11-08
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
APPLE INC40Q3 20231.4%
ABBVIE INC40Q3 20234.2%
C V S HEALTH CORPORATION39Q3 20230.9%
UNITEDHEALTH GRP INC38Q3 20230.9%
EAGLE PHARMACEUTICALS37Q3 20230.7%
MICROSOFT CORP36Q3 20232.1%
BOEING CO36Q3 20231.0%
HONEYWELL INTL INC TRADES WITH DUE BILLS34Q3 20230.8%
LYONDELLBASELL INDS F DUTCH TENDER EXP: 07/08/1934Q3 20230.6%
JOHNSON & JOHNSON34Q3 20230.5%

View Stanley-Laman Group, Ltd.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-17
13F-HR2024-02-02
13F-HR2023-10-16
13F-HR2023-08-08
13F-HR2023-04-18
13F-HR2023-01-19
13F-HR2022-10-18
13F-HR2022-08-08
13F-HR2022-04-21
13F-HR2022-01-25

View Stanley-Laman Group, Ltd.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (405018000.0 != 405020000.0)

Export Stanley-Laman Group, Ltd.'s holdings